{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:12:47Z","timestamp":1790741567030,"version":"4.1.0"},"reference-count":384,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.addr.2021.113911","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T11:41:52Z","timestamp":1627990912000},"page":"113911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Therapeutic and delivery strategies of phytoconstituents for renal fibrosis"],"prefix":"10.1016","volume":"177","author":[{"given":"Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leaf","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.113911_b0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and molecular mechanisms of kidney fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.addr.2021.113911_b0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-981-13-8871-2_18","article-title":"Inflammatory mediators and renal fibrosis","volume":"1165","author":"Meng","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-981-13-8871-2_15","article-title":"Role of aldosterone in renal fibrosis","volume":"1165","author":"Shrestha","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/978-981-13-8871-2_29","article-title":"Oxidative stress and renal fibrosis: mechanisms and therapies","volume":"1165","author":"Su","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-981-13-8871-2_3","article-title":"Current opinion for hypertension in renal fibrosis","volume":"1165","author":"Sun","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/978-981-13-8871-2_28","article-title":"Cell apoptosis and autophagy in renal fibrosis","volume":"1165","author":"Zhao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diff.2016.05.008","article-title":"The origin of renal fibroblasts\/myofibroblasts and the signals that trigger fibrosis","volume":"92","author":"Sun","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.addr.2021.113911_b0045","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2021.113911_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.113911_b0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.113911_b0060","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2021.113911_b0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.113911_b0070","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3902","article-title":"Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis","volume":"21","author":"Lovisa","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.113911_b0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2015.04.013","article-title":"Recent advances in traditional Chinese medicine for kidney disease","volume":"66","author":"Zhong","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.addr.2021.113911_b0080","first-page":"44","article-title":"Herbal treatment for renal diseases","volume":"34","author":"Peng","year":"2005","journal-title":"Ann Acad Med"},{"key":"10.1016\/j.addr.2021.113911_b0085","first-page":"2019","article-title":"Historical story on natural medicinal chemistry: Great charm of study on natural product chemistry","volume":"46","author":"Guo","year":"2015","journal-title":"Chin J Tradit Herb Drug"},{"key":"10.1016\/j.addr.2021.113911_b0090","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2174\/1381612824666180829103355","article-title":"Chinese herbal formulas and renal fibrosis: an overview","volume":"24","author":"Shen","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2021.113911_b0095","first-page":"215","article-title":"Research progress of prevention and treatment of renal fibrosis with traditional Chinese medicine","volume":"19","author":"Wang","year":"2017","journal-title":"J. Liaoning Univ. TCM"},{"key":"10.1016\/j.addr.2021.113911_b0100","first-page":"396","article-title":"Protective effects of quercetin on chronic cyclosporine nephropathy in rats","volume":"35","author":"Tan","year":"2012","journal-title":"Acta Acad. Med. Zunyi"},{"key":"10.1016\/j.addr.2021.113911_b0105","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1039\/C9FO00373H","article-title":"Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.addr.2021.113911_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2015.06.006","article-title":"Quercetin inhibits the mTORC1\/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy","volume":"99","author":"Lu","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2021.113911_b0115","doi-asserted-by":"crossref","first-page":"23968","DOI":"10.1038\/srep23968","article-title":"Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and beta-catenin Signaling","volume":"6","author":"Ren","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118116","article-title":"Quercetin alleviates kidney fibrosis by reducing renal tubular epithelial cell senescence through the SIRT1\/PINK1\/mitophagy axis","volume":"257","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153185","article-title":"Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway","volume":"69","author":"Wang","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1248\/bpb.b19-01010","article-title":"Kaempferol protects renal fibrosis through activating the BMP-7-Smad1\/5 signaling pathway","volume":"43","author":"Ji","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2021.113911_b0135","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","article-title":"Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-alpha and TGF-\u03b21-MAPK-fibronectin pathways","volume":"313","author":"Malik","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b0140","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.18632\/aging.103410","article-title":"CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD(+)\/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats","volume":"12","author":"Ogura","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.addr.2021.113911_b0145","first-page":"2006","article-title":"Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis","volume":"13","author":"Hou","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2021.113911_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopha.2018.06.138","article-title":"Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression","volume":"106","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.fct.2016.07.030","article-title":"Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis","volume":"96","author":"Chen","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b0160","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1039\/D0FO01542C","article-title":"EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGFbeta\/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice","volume":"11","author":"Zhu","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.addr.2021.113911_b0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.106.107029","article-title":"Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats","volume":"319","author":"Yamabe","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2021.113911_b0170","article-title":"Epigallocatechin gallate (EGCG) improves epithelial mesenchymal transformation of HK-2 cells by inhibiting autophagy","author":"Xu","year":"2018","journal-title":"China Med. Univ."},{"key":"10.1016\/j.addr.2021.113911_b0175","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3892\/mmr.2017.6208","article-title":"Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor \u03b21 production and downstream signal transduction","volume":"15","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s13105-020-00747-z","article-title":"Baicalin suppresses renal fibrosis through microRNA-124\/TLR4\/NF-\u03baB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells","volume":"76","author":"Zhang","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bju.13219","article-title":"Baicalein ameliorates renal interstitial fibrosis by inducing myofibroblast apoptosis in vivo and in vitro","volume":"118","author":"Wang","year":"2016","journal-title":"BJU Int."},{"key":"10.1016\/j.addr.2021.113911_b0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10735-015-9621-8","article-title":"Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-\u03baB and MAPK signal pathways","volume":"46","author":"Wang","year":"2015","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.addr.2021.113911_b0195","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2147\/DDDT.S274256","article-title":"Wogonin ameliorates renal inflammation and fibrosis by inhibiting NF-\u03baB and TGF-\u03b21\/Smad3 signaling pathways in diabetic nephropathy","volume":"14","author":"Zheng","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.addr.2021.113911_b0200","first-page":"329","article-title":"Breviscapine attenuatted contrast medium-induced nephropathy via PKC\/Akt\/MAPK signalling in diabetic mice","volume":"8","author":"Jiang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2021.113911_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152917","article-title":"The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model","volume":"59","author":"Chen","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/2211-5463.12161","article-title":"Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa B\/Nlrp3 pathway","volume":"7","author":"Zhang","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.addr.2021.113911_b0215","article-title":"Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/0886022X.2017.1305409","article-title":"Puerarin attenuates renal fibrosis by reducing oxidative stress induced-epithelial cell apoptosis via MAPK signal pathways in vivo and in vitro","volume":"39","author":"Zhou","year":"2017","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00109-019-01759-z","article-title":"Klotho recovery by genistein via promoter histone acetylation and DNA demethylation mitigates renal fibrosis in mice","volume":"97","author":"Li","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.addr.2021.113911_b0230","first-page":"423","article-title":"Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats","volume":"19","author":"Jia","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0235","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41419-020-03260-9","article-title":"Isoliquiritigenin prevents hyperglycemia-induced renal injuries by inhibiting inflammation and oxidative stress via SIRT1-dependent mechanism","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2021.113911_b0240","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/DDDT.S243420","article-title":"Isoliquiritigenin attenuates UUO-induced renal inflammation and fibrosis by inhibiting Mincle\/Syk\/NF-Kappa B signaling pathway","volume":"14","author":"Liao","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.addr.2021.113911_b0245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00109-015-1301-3","article-title":"Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition","volume":"93","author":"Kang","year":"2015","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.addr.2021.113911_b0250","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2147\/DDDT.S209981","article-title":"Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy","volume":"13","author":"Liu","year":"2019","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.addr.2021.113911_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/670106","article-title":"Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathy","volume":"2014","author":"Sun","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.addr.2021.113911_b0260","article-title":"Hydroxysafflor yellow A ameliorates renal fibrosis by suppressing TGF-\u03b21-induced epithelial-to-mesenchymal transition","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2020.05.087","article-title":"Hesperetin inhibit EMT in TGF-\u03b2 treated podocyte by regulation of mTOR pathway","volume":"528","author":"Choi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.113911_b0270","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.3892\/etm.2017.4968","article-title":"Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.113911_b0275","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7150\/ijms.31075","article-title":"Naringenin ameliorates renovascular hypertensive renal damage by normalizing the balance of renin-angiotensin system components in rats","volume":"16","author":"Wang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0280","article-title":"Naringin alleviates diabetic kidney disease through inhibiting oxidative stress and inflammatory reaction","volume":"10","author":"Sen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2020.00049","article-title":"Mangiferin ameliorates hyperuricemic nephropathy which is associated with downregulation of aqp2 and increased urinary uric acid excretion","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ptr.5254","article-title":"Mangiferin attenuates renal fibrosis through down-regulation of osteopontin in diabetic rats","volume":"29","author":"Zhu","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2021.113911_b0295","doi-asserted-by":"crossref","first-page":"9481720","DOI":"10.1155\/2020\/9481720","article-title":"Mangiferin alleviates renal interstitial fibrosis in streptozotocin-induced diabetic mice through regulating the PTEN\/PI3K\/Akt signaling pathway","volume":"2020","author":"Song","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.addr.2021.113911_b0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.intimp.2016.03.029","article-title":"Rutin ameliorates kidney interstitial fibrosis in rats with obstructive nephropathy","volume":"35","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0305","article-title":"Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway","author":"Zhang","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.addr.2021.113911_b0310","first-page":"4589","article-title":"Quercetin suppresses glomerulosclerosis and TGF-\u03b2 signaling in a rat model","volume":"19","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0315","first-page":"2442","article-title":"Quercetin is able to alleviate TGF-\u03b2-induced fibrosis in renal tubular epithelial cells by suppressing miR-21","volume":"16","author":"Cao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.113911_b0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2018.05.007","article-title":"Quercetin ameliorates kidney injury and fibrosis by modulating M1\/M2 macrophage polarization","volume":"154","author":"Lu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0325","first-page":"555","article-title":"Stereological survey of the ameliorative effects of sulforaphane and quercetin on renal tissue in unilateral ureteral obstruction in rats","volume":"51","author":"Noorafshan","year":"2012","journal-title":"Acta Clin. Croat"},{"key":"10.1016\/j.addr.2021.113911_b0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2018.01.026","article-title":"Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome","volume":"41","author":"Ding","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0335","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.biopha.2018.10.195","article-title":"Kaempferol attenuates diabetic nephropathy by inhibiting RhoA\/Rho-kinase mediated inflammatory signalling","volume":"109","author":"Sharma","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113553","article-title":"Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy","volume":"268","author":"Luo","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0345","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20160780","article-title":"Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension","volume":"131","author":"Wei","year":"2017","journal-title":"Clin Sci. (Lond.)"},{"key":"10.1016\/j.addr.2021.113911_b0350","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/advances\/nmy077","article-title":"Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases","volume":"10","author":"Kanlaya","year":"2019","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.addr.2021.113911_b0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biopha.2015.01.032","article-title":"Epigallocatechin-3-gallate attenuates transforming growth factor-\u03b21 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells","volume":"70","author":"Wang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0360","doi-asserted-by":"crossref","first-page":"30233","DOI":"10.1038\/srep30233","article-title":"Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells","volume":"6","author":"Kanlaya","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0365","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1021\/acs.jafc.7b03301","article-title":"Impact of EGCG supplementation on the progression of diabetic nephropathy in rats: an insight into fibrosis and apoptosis","volume":"65","author":"Mohan","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.addr.2021.113911_b0370","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1369\/0022155414568019","article-title":"Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice","volume":"63","author":"Wang","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2021.113911_b0375","article-title":"Effects and possible mechanism of baicalin on renal interstitial fibrosis in unilateral ureteral obstruction rat","volume":"46","author":"Ma","year":"2017","journal-title":"Chongqing Med."},{"key":"10.1016\/j.addr.2021.113911_b0380","first-page":"365","article-title":"Therapeutic effect of baicalin in treatment of renal interstitial fibrosis in rats with unilateral ureteral obstruction and related mechanisms","volume":"18","author":"Tan","year":"2016","journal-title":"Chin. J. Contemp. Pediatrics"},{"key":"10.1016\/j.addr.2021.113911_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117742","article-title":"Baicalin attenuates fibrogenic process in human renal proximal tubular cells (HK-2) exposed to diabetic milieu","volume":"254","author":"Nam","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b0390","first-page":"524","article-title":"Comparison of pharmacokinetics of baicalein and baicalin in rats","author":"Guo","year":"2008","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.addr.2021.113911_b0395","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3892\/etm.2017.4888","article-title":"Baicalin and baicalein attenuate renal fibrosis in vitro via inhibition of the TGF-beta1 signaling pathway","volume":"14","author":"Hu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.113911_b0400","first-page":"573","article-title":"Breviscapine prevents downregulation of renal water and sodium transport proteins in response to unilateral ureteral obstruction","volume":"19","author":"Mei","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0405","first-page":"151","article-title":"Effect of breviscapine on serum fibrosis and arterial elasticity indexes in patients with hypertensive nephropathy","volume":"36","author":"Zhao","year":"2016","journal-title":"Chin. J. Biochem. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b0410","first-page":"611","article-title":"Protective effect of Icariin on angiotensin II induced renal fibrosis","volume":"43","author":"Gu","year":"2020","journal-title":"Shanghai Med. J."},{"key":"10.1016\/j.addr.2021.113911_b0415","first-page":"385","article-title":"Icariin regulates the fibrosis and inflammatory reaction in IgA nephropathy","volume":"34","author":"Zhao","year":"2018","journal-title":"Immunol. J."},{"key":"10.1016\/j.addr.2021.113911_b0420","first-page":"519","article-title":"Icariin attenuates renal interstitial fibrosis by reducing aldosterone in SHR","volume":"30","author":"Li","year":"2014","journal-title":"Chin. Pharm. Bull."},{"key":"10.1016\/j.addr.2021.113911_b0425","first-page":"40","article-title":"A review on the molecular mechanism of treating DN by puerarin","volume":"8","author":"Wang","year":"2016","journal-title":"Clin. J. Chin. Med."},{"key":"10.1016\/j.addr.2021.113911_b0430","unstructured":"Y.E. Yi, Y.N. Nie, S.Y. li, Y.J. Li, X.L. Chai, D.X. Jia, Q. Wang, Effect of puerarin injection on epithelial-mesenchymal transition in renal tubular epithelial cells of diabetic KKAy mice, Chin. J. Pathophysiol. 29 (2013) 2263\u20132267."},{"key":"10.1016\/j.addr.2021.113911_b0435","first-page":"26","article-title":"Antihypertensive effect of puerarin in renal hypertensive rats and its effect on level of angiotensin II in renal tissue","volume":"26","author":"Zhang","year":"2010","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"key":"10.1016\/j.addr.2021.113911_b0440","first-page":"32","article-title":"Anti-lung cancer mechanism of natural quinonoids","volume":"25","author":"Zhong","year":"2019","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.addr.2021.113911_b0445","unstructured":"P.P. Zhao, J.M. Tong, Q.F. Tian, S.F. Zhang, Research progress on pharmacological effects of anthraquinone compounds, J. Chengde Med. Univ. 33 (2016) 152\u2013155."},{"key":"10.1016\/j.addr.2021.113911_b0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11255-017-1757-x","article-title":"Emodin ameliorates renal fibrosis in rats via TGF-\u03b21\/Smad signaling pathway and function study of Smurf 2","volume":"50","author":"Ma","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b0455","first-page":"29","article-title":"The effect and significance of emodin on expression of tissue inhibitor of platelet derived growth factors-B (PDGF-B)in rat with renal tubular interstitial fibrosis","volume":"24","author":"Sun","year":"2016","journal-title":"Chin. J. Birth Health Hered"},{"key":"10.1016\/j.addr.2021.113911_b0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbrc.2020.11.094","article-title":"Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2","volume":"534","author":"Xu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.113911_b0465","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/rej.2018.2104","article-title":"Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K\/Akt\/mTOR signaling pathway in vivo and in vitro","volume":"22","author":"Dou","year":"2019","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.addr.2021.113911_b0470","doi-asserted-by":"crossref","first-page":"34597","DOI":"10.1038\/srep34597","article-title":"Rhein reversal of DNA hypermethylation-associated Klotho suppression ameliorates renal fibrosis in mice","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0253-7613.150319","article-title":"Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy","volume":"47","author":"Chen","year":"2015","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0480","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1248\/bpb.34.1219","article-title":"Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy","volume":"34","author":"He","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2021.113911_b0485","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.transproceed.2013.03.030","article-title":"Chronic allograft nephropathy in rats is improved by the intervention of rhein","volume":"45","author":"Su","year":"2013","journal-title":"Transplant Proc."},{"key":"10.1016\/j.addr.2021.113911_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114079","article-title":"Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-\u03b2\/Smad signaling pathway","volume":"180","author":"Dou","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0495","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/867140","article-title":"Tanshinone IIA attenuates renal fibrosis after acute kidney injury in a mouse model through inhibition of fibrocytes recruitment","volume":"2015","author":"Jiang","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2021.113911_b0500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","article-title":"Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-\u03b2\/Smad and NF-\u03baB signaling pathway in 5\/6 nephrectomized rats","volume":"26","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0505","unstructured":"F. Zhao, Effect of tanshinone II A on TGF- \u03b21\/Smads signaling pathway in HK-2 cells induced by TGF-\u03b2 1, Beijing Univ. Chin. Med. (2014)."},{"key":"10.1016\/j.addr.2021.113911_b0510","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4314\/tjpr.v19i4.9","article-title":"Tanshinone IIA suppresses fibrosis induced by high glucose conditions in HK-2 cells via inhibition of extracellular matrix deposition, reduction of oxidative stress, and inhibition of epithelial to mesenchymal transition","volume":"19","author":"Zhao","year":"2020","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.addr.2021.113911_b0515","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.3892\/mmr.2017.6498","article-title":"Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis","volume":"15","author":"Cao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0520","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bcpt.13091","article-title":"Cryptotanshinone attenuates oxidative stress and inflammation through the regulation of Nrf-2 and NF-\u03baB in mice with unilateral ureteral obstruction","volume":"123","author":"Wang","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b0525","doi-asserted-by":"crossref","first-page":"26625","DOI":"10.18632\/oncotarget.23803","article-title":"Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-\u03b21\/Smad3\/integrin \u03b21 signal","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2021.113911_b0530","doi-asserted-by":"crossref","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","article-title":"Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis","volume":"313","author":"Ding","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073428","article-title":"Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling","volume":"8","author":"Yong","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b0540","first-page":"1093","article-title":"Effects of emodin on proliferation of NRK-49F cells induced by TGF-\u03b21","volume":"14","author":"Ji","year":"2019","journal-title":"World Chin. Med."},{"key":"10.1016\/j.addr.2021.113911_b0545","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2009.03.006","article-title":"Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose","volume":"307","author":"Li","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2021.113911_b0550","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.lfs.2007.04.010","article-title":"Emodin suppresses interleukin-1\u03b2 induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK","volume":"80","author":"Wang","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b0555","article-title":"Mechanism of Rhubarb against renal fibrosis based on lipomics and autophagy","author":"Fang","year":"2018","journal-title":"Air Force Med. Univ."},{"key":"10.1016\/j.addr.2021.113911_b0560","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jphp.13234","article-title":"Renal protection of rhein against 5\/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3\u03b1 signalling pathway","volume":"72","author":"Wu","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0565","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40659-019-0257-0","article-title":"Rhein alleviates renal interstitial fibrosis by inhibiting tubular cell apoptosis in rats","volume":"52","author":"Chen","year":"2019","journal-title":"Biol. Res."},{"key":"10.1016\/j.addr.2021.113911_b0570","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2008.01.059","article-title":"Participation of autophagy in renal ischemia\/reperfusion injury","volume":"368","author":"Suzuki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.113911_b0575","doi-asserted-by":"crossref","first-page":"43790","DOI":"10.1038\/srep43790","article-title":"Rhein inhibits autophagy in rat renal tubular cells by regulation of AMPK\/mTOR signaling","volume":"7","author":"Tu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113106","article-title":"Quantitative and network pharmacology: A case study of rhein alleviating pathological progress of renal interstitial fibrosis","volume":"261","author":"Shen","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0585","unstructured":"L.Z. Zhang, J. Li, Research progress of pharmacologic actions of tanshinone IIA, J. Biol. 25 (2019) 1255\u20131259+1265."},{"key":"10.1016\/j.addr.2021.113911_b0590","first-page":"1149","article-title":"The effects of tanshinone IIA on oxidative stress of the kidneys of rats with diabetic nephropathy","volume":"9","author":"Wang","year":"2015","journal-title":"Chin. J. Clin."},{"key":"10.1016\/j.addr.2021.113911_b0595","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2121-11-31","article-title":"Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-\u03b21 signal transduction pathway in vivo and in vitro","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.addr.2021.113911_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110241","article-title":"Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy","volume":"128","author":"He","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0605","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3892\/mmr.2020.11229","article-title":"Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE\/SDC1 axis","volume":"22","author":"Hu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0610","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/s41401-018-0026-6","article-title":"Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-\u03baB and p38 MAPK signaling pathways in 5\/6 nephrectomized rats","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.addr.2021.113911_b0615","first-page":"9","article-title":"The regulating role of salvianolic acid A on BMP-7\/Smads\/TGF-\u03b21 signaling pathway in chronic renal failure rats","volume":"18","author":"Tang","year":"2017","journal-title":"Chin. J. Integr. Tradit. West Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b0620","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.3892\/mmr.2016.5601","article-title":"Curcumin attenuates cyclosporine A-induced renal fibrosis by inhibiting hypermethylation of the klotho promoter","volume":"14","author":"Hu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1248\/bpb.b16-00364","article-title":"Curcumin suppresses epithelial-mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt\/mTOR pathway","volume":"40","author":"Zhu","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2021.113911_b0630","first-page":"48","article-title":"Curcumin inhibits TGF-\u03b21-induced phenotypic transition of human kidney tubular cells (HKCs)","volume":"40","author":"Chen","year":"2020","journal-title":"Basic Clin Med"},{"key":"10.1016\/j.addr.2021.113911_b0635","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1254\/jphs.14173FP","article-title":"Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition","volume":"126","author":"Zhou","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0640","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.amjms.2015.12.017","article-title":"Curcumin Rescues diabetic renal fibrosis by targeting superoxide-mediated Wnt signaling pathways","volume":"351","author":"Ho","year":"2016","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0645","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mnfr.201200540","article-title":"Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway","volume":"57","author":"Soetikno","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.addr.2021.113911_b0650","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1523-1755.2005.00658.x","article-title":"Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1","volume":"68","author":"Gaedeke","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.addr.2021.113911_b0655","first-page":"12696","article-title":"Curcumin prevents adriamycin-induced nephropathy MCP-1 expression through blocking histone acetylation","volume":"9","author":"Liu","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.addr.2021.113911_b0660","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","article-title":"Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway","volume":"41","author":"Chen","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.addr.2021.113911_b0665","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2017.03.003","article-title":"Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys","volume":"106","author":"Gong","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.addr.2021.113911_b0670","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mce.2014.08.014","article-title":"Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-\u03b21 in rat glomerular messangial cells","volume":"399","author":"Huang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2021.113911_b0675","first-page":"1274","article-title":"Therapeutic effect of polydatin on renal interstitial fibrosis in rats with unilateral ureteral obstruction","volume":"36","author":"Li","year":"2020","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.addr.2021.113911_b0680","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2014.09.002","article-title":"Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway","volume":"92","author":"Bai","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0685","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2011.01.033","article-title":"Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-\u03b2\/smad and ERK1\/2 signaling in streptozotocin-induced diabetic rats","volume":"190","author":"Chen","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.addr.2021.113911_b0690","first-page":"1609","article-title":"Study on the mechanism of resveratrol on renal fibrosis in chronic renal failure model","volume":"35","author":"Liu","year":"2019","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.addr.2021.113911_b0695","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00109-016-1451-y","article-title":"Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK\/NOX4\/ROS pathway","volume":"94","author":"He","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.addr.2021.113911_b0700","first-page":"893","article-title":"Effect of resveratrol on autophagy and renal interstitial fibrosis in kidney of diabetic mice","volume":"36","author":"Zhao","year":"2020","journal-title":"Chin J Pathophysiol"},{"key":"10.1016\/j.addr.2021.113911_b0705","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000479525","article-title":"Resveratrol attenuates adriamycin-induced focal segmental glomerulosclerosis through C3aR\/C5aR-sphingosine kinase 1 pathway","volume":"100","author":"Liu","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.addr.2021.113911_b0710","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2018.10.008","article-title":"Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-\u03b21\/TGF-\u03b2 type I receptor\/Smads signaling in proximal tubular epithelial cells","volume":"842","author":"Gu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0715","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.biopha.2018.11.022","article-title":"Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy","volume":"109","author":"Pan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0720","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1142\/S0192415X20500858","article-title":"Pterostilbene, a bioactive component of blueberries, alleviates renal interstitial fibrosis by inhibiting macrophage-myofibroblast transition","volume":"48","author":"Feng","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.addr.2021.113911_b0725","first-page":"1","article-title":"Induction of autophagy by pterostilbene contributes to the prevention of renal fibrosis via attenuating NLRP3 inflammasome activation and epithelial-mesenchymal transition","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2021.113911_b0730","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/ijms21020402","article-title":"Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-kappaBTGF-beta1\/Smad Signaling Pathway","volume":"21","author":"Quan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0735","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1476-5381.2011.01242.x","article-title":"Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro","volume":"163","author":"Chiang","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0740","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00394-011-0274-4","article-title":"Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db\/db mice","volume":"51","author":"Li","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.addr.2021.113911_b0745","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.3892\/mmr.2015.4445","article-title":"Procyanidin B2 inhibits high glucose-induced epithelial-mesenchymal transition in HK-2 human renal proximal tubular epithelial cells","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0750","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12272-011-0317-7","article-title":"Salvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-\u03b2","volume":"34","author":"Pan","year":"2011","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.addr.2021.113911_b0755","first-page":"51","article-title":"Ameliorative effect of salvianolic acid B on renal fibrosis in diabetic rats and potential mechanisms implicated","volume":"35","author":"Zhang","year":"2019","journal-title":"Chin Pharm Bull"},{"key":"10.1016\/j.addr.2021.113911_b0760","first-page":"2201","article-title":"Salvianolic acid B improves renal fibrosis in UUO mice by regulating autophagy","volume":"41","author":"Huang","year":"2018","journal-title":"J Chin Med Mater"},{"key":"10.1016\/j.addr.2021.113911_b0765","doi-asserted-by":"crossref","first-page":"2418671","DOI":"10.1155\/2017\/2418671","article-title":"Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis","volume":"2017","author":"Sun","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.addr.2021.113911_b0770","article-title":"Curcumin inhibits transforming growth factor-beta1-induced EMT via PPARgamma pathway, not Smad pathway in renal tubular epithelial cells","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b0775","article-title":"The protective effects and mechanisms of curcumin on renal tubulointerstitial fibrosis","author":"Hu","year":"2010","journal-title":"Zhejiang Univ"},{"key":"10.1016\/j.addr.2021.113911_b0780","unstructured":"Y. Liu, Experimental study on the molecular mechanism of curcumin against renal interstitial fibrosis based on miRNAs, Beijing Univ. Chin. Med. (2018)."},{"key":"10.1016\/j.addr.2021.113911_b0785","doi-asserted-by":"crossref","unstructured":"H.T. Chen, Y.L. Fan, F. Huang, H.H. Peng, Z.Y. Zhong, J. Zhou, Curcumin alleviates ischemia reperfusion-induced late kidney fibrosis through the APPL1\/Akt signaling pathway, J. Cell Physiol. 233 (2018) 8588\u20138596.","DOI":"10.1002\/jcp.26536"},{"key":"10.1016\/j.addr.2021.113911_b0790","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcb.24748","article-title":"Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-\u03b2\/Smad3 pathway","volume":"115","author":"Huang","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b0795","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1535370215598401","article-title":"Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-\u03b2 pathway on matrix metalloproteinase 7","volume":"241","author":"Xiao","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.addr.2021.113911_b0800","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.3390\/ijms21186766","article-title":"Resveratrol pretreatment ameliorates concanavalin A-induced advanced renal glomerulosclerosis in aged mice through upregulation of Sirtuin 1-mediated klotho expression","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.113911_b0805","article-title":"Resveratrol reduces gentamicin-induced EMT in the kidney via inhibition of reactive oxygen species and involving TGF-\u03b2\/Smad pathway","volume":"258","author":"Beshay","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b0810","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0886022X.2013.844644","article-title":"Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction","volume":"36","author":"Liang","year":"2014","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b0815","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2353\/ajpath.2010.090923","article-title":"Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3","volume":"177","author":"Li","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2021.113911_b0820","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/0886022X.2016.1149774","article-title":"Regulation of eIF2alpha expression and renal interstitial fibrosis by resveratrol in rat renal tissue after unilateral ureteral obstruction","volume":"38","author":"Zhang","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b0825","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1535370214532597","article-title":"Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-\u03b2\/Smad signaling pathway in vivo and in vitro","volume":"239","author":"Wang","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.addr.2021.113911_b0830","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/jpet.114.214205","article-title":"Astragaloside IV ameliorates renal fibrosis via the inhibition of mitogen-activated protein kinases and antiapoptosis in vivo and in vitro","volume":"350","author":"Xu","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2021.113911_b0835","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.intimp.2016.11.006","article-title":"Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4\/NF-\u043aB in vivo and in vitro","volume":"42","author":"Zhou","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b0840","first-page":"5029","article-title":"Astragaloside IV attenuates renal fibrosis through repressing epithelial-to-mesenchymal transition by inhibiting microRNA-192 expression: in vivo and in vitro studies","volume":"11","author":"Cao","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2021.113911_b0845","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1631\/jzus.B0820024","article-title":"Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction","volume":"9","author":"Xie","year":"2008","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.addr.2021.113911_b0850","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3109\/0886022X.2015.1015427","article-title":"Ginsenoside-Rg1 inhibits endoplasmic reticulum stress-induced apoptosis after unilateral ureteral obstruction in rats","volume":"37","author":"Li","year":"2015","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b0855","doi-asserted-by":"crossref","first-page":"1903627","DOI":"10.1155\/2020\/1903627","article-title":"Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT\/GSK3 beta\/beta-Catenin Pathway by Restoring Autophagic Activity","volume":"2020","author":"Shi","year":"2020","journal-title":"Evid-Based Compl. Alt."},{"key":"10.1016\/j.addr.2021.113911_b0860","doi-asserted-by":"crossref","first-page":"7152176","DOI":"10.1155\/2020\/7152176","article-title":"20(S)-Ginsenoside Rg3 protects kidney from diabetic kidney disease via renal inflammation depression in diabetic rats","volume":"2020","author":"Zhou","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.addr.2021.113911_b0865","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11655-009-0133-9","article-title":"Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction","volume":"15","author":"Xie","year":"2009","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.addr.2021.113911_b0870","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijbiomac.2020.07.060","article-title":"Ginsenoside Rb1 ameliorates autophagy via the AMPK\/mTOR pathway in renal tubular epithelial cells in vitro and in vivo","volume":"163","author":"Liu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2021.113911_b0875","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/molecules24020247","article-title":"Notoginsenoside R1 protects db\/db mice against diabetic nephropathy via upregulation of Nrf2-Mediated HO-1 expression","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2021.113911_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153163","article-title":"Saikosaponin B2 attenuates kidney fibrosis via inhibiting the Hedgehog Pathway","volume":"67","author":"Ren","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0885","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5301\/JN.2010.1944","article-title":"Gypenosides inhibit renal fibrosis by regulating expression of related genes in rats with unilateral ureteral obstruction","volume":"24","author":"Zhang","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b0890","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1111\/jcmm.14340","article-title":"Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting \u03b2-catenin activity","volume":"23","author":"Huang","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2021.113911_b0895","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phymed.2018.10.031","article-title":"Salidroside stimulates the Sirt1\/PGC-1alpha axis and ameliorates diabetic nephropathy in mice","volume":"54","author":"Xue","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0900","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1111\/jcmm.15539","article-title":"Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2021.113911_b0905","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3892\/mmr.2013.1391","article-title":"Amygdalin inhibits renal fibrosis in chronic kidney disease","volume":"7","author":"Guo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b0910","article-title":"Protective effect of Hyperoside on LPS-induced acute kidney injury and the underlying mechanisms","author":"Gong","year":"2019","journal-title":"Shandong Univ."},{"key":"10.1016\/j.addr.2021.113911_b0915","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.biopha.2018.04.137","article-title":"Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool","volume":"103","author":"Qin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2021.113911_b0920","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.phymed.2013.02.010","article-title":"Paeoniflorin of Paeonia lactiflora prevents renal interstitial fibrosis induced by unilateral ureteral obstruction in mice","volume":"20","author":"Zeng","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105192","article-title":"Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis","volume":"160","author":"Zhou","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2021.113911_b0930","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1159\/000358699","article-title":"Astragaloside IV inhibits the up-regulation of Wnt\/\u03b2-catenin signaling in rats with unilateral ureteral obstruction","volume":"33","author":"Wang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b0935","first-page":"709","article-title":"Astragaloside IV ameliorates high glucose-induced renal tubular epithelial-mesenchymal transition by blocking mTORC1\/p70S6K signaling in HK-2 cells","volume":"43","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2021.113911_b0940","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbrc.2015.07.116","article-title":"Astragaloside IV suppresses transforming growth factor-\u03b21 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-\u03baB signaling pathways","volume":"464","author":"Che","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.113911_b0945","first-page":"3053","article-title":"Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-\u03b21\/Smad\/miR-192 signaling pathway","volume":"18","author":"Mao","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.addr.2021.113911_b0950","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/DDDT.S170840","article-title":"Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice","volume":"12","author":"Wang","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b0955","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1248\/bpb.b17-00934","article-title":"Ginsenoside-Rg1 protects against renal fibrosis by regulating the Klotho\/TGF-\u03b21\/Smad signaling pathway in rats with obstructive nephropathy","volume":"41","author":"Li","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2021.113911_b0960","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.transproceed.2014.10.047","article-title":"Ginsenoside Rg1 protects chronic cyclosporin a nephropathy from tubular cell apoptosis by inhibiting endoplasmic reticulum stress in rats","volume":"47","author":"Liu","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.addr.2021.113911_b0965","doi-asserted-by":"crossref","first-page":"2085303","DOI":"10.1155\/2020\/2085303","article-title":"Oleanolic acid attenuates renal fibrosis through TGF-\u03b2\/Smad pathway in a rat model of unilateral ureteral obstruction","volume":"2020","author":"Zhao","year":"2020","journal-title":"Evid-Based. Compl. Alt."},{"key":"10.1016\/j.addr.2021.113911_b0970","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-7075-11-2","article-title":"Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2","volume":"11","author":"Chung","year":"2014","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.addr.2021.113911_b0975","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10616-019-00335-0","article-title":"Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p\/PTEN signaling","volume":"71","author":"Chen","year":"2019","journal-title":"Cytotechnology"},{"key":"10.1016\/j.addr.2021.113911_b0980","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/814089","article-title":"Protective effect of triptolide against glomerular mesangial cell proliferation and glomerular fibrosis in rats involves the TGF- \u03b21\/Smad signaling pathway","volume":"2015","author":"Cao","year":"2015","journal-title":"Evid.-Based Compl. Alt."},{"key":"10.1016\/j.addr.2021.113911_b0985","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.omtn.2017.08.011","article-title":"Triptolide restores autophagy to alleviate diabetic renal fibrosis through the mir-141-3p\/PTEN\/Akt\/mTOR pathway","volume":"9","author":"Li","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2021.113911_b0990","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41419-018-0666-y","article-title":"Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2021.113911_b0995","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/jcb.27714","article-title":"Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-\u03baB\/NLRP3 pathway in rats with 5\/6 subtotal nephrectomy","volume":"120","author":"Wen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b1000","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cbi.2018.02.001","article-title":"Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats","volume":"284","author":"Abou-Hany","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.addr.2021.113911_b1005","first-page":"337","article-title":"Protective effect of crocin on gentamicin-induced nephrotoxicity in rats, Iran J Basic","volume":"19","author":"Yarijani","year":"2016","journal-title":"Med Sci"},{"key":"10.1016\/j.addr.2021.113911_b1010","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2147\/DDDT.S81390","article-title":"Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b1015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/path.2961","article-title":"Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192","volume":"225","author":"Sun","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2021.113911_b1020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13880209.2019.1577464","article-title":"Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo","volume":"57","author":"Xu","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.addr.2021.113911_b1025","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2147\/DMSO.S222323","article-title":"Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1\/AT1R Signaling Pathway","volume":"12","author":"Ma","year":"2019","journal-title":"Diabet Metab Synd Ob"},{"key":"10.1016\/j.addr.2021.113911_b1030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092236","article-title":"Pomolic acid ameliorates fibroblast activation and renal interstitial fibrosis through inhibition of SMAD-STAT signaling pathways","volume":"23","author":"Park","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2021.113911_b1035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3892\/etm.2013.1197","article-title":"Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction","volume":"6","author":"Xu","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.addr.2021.113911_b1040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12906-018-2265-y","article-title":"Oleanolic acid attenuates TGF-\u03b21-induced epithelial-mesenchymal transition in NRK-52E cells","volume":"18","author":"He","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.addr.2021.113911_b1045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1479-5876-12-50","article-title":"Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2\/HO-1 signaling","volume":"12","author":"Hong","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.addr.2021.113911_b1050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ndt\/gfv377","article-title":"Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model","volume":"31","author":"Lee","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.addr.2021.113911_b1055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1440-1797.2010.01359.x","article-title":"Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction","volume":"16","author":"Yuan","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.addr.2021.113911_b1060","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/ndt\/gfq239","article-title":"Triptolide inhibits extracellular matrix protein synthesis by suppressing the Smad2 but not the MAPK pathway in TGF-\u03b21-stimulated NRK-49F cells","volume":"25","author":"Zhu","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.addr.2021.113911_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107035","article-title":"Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension","volume":"89","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/ijms17081327","article-title":"Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice","volume":"17","author":"Zhang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/nep.12271","article-title":"Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats","volume":"19","author":"Wang","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.addr.2021.113911_b1080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2147\/DDDT.S124971","article-title":"Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch\/snail pathway in diabetic nephropathy model KKAy mice","volume":"11","author":"Yang","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b1085","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3892\/mmr.2017.6707","article-title":"Protective effect of berberine on renal fibrosis caused by diabetic nephropathy","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b1090","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e4e8ca0c-f6e8-4b32-aae1-b5f8e0c7ebc3","article-title":"Berberine reduces fibronectin expression by suppressing the S1P\u2013S1P2 receptor pathway in experimental diabetic nephropathy models","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b1095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2010.04.033","article-title":"Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury","volume":"638","author":"Liu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/1440-1681.12402","article-title":"Renoprotective effect of berberine on type 2 diabetic nephropathy in rats","volume":"42","author":"Sun","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b1105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2013.07.019","article-title":"Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA\/ROCK signaling","volume":"381","author":"Xie","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2021.113911_b1110","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.7150\/thno.30640","article-title":"Berberine protects glomerular podocytes via inhibiting Drp1-mediated mitochondrial fission and dysfunction","volume":"9","author":"Qin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2021.113911_b1115","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/bph.14935","article-title":"Berberine protects against diabetic kidney disease via promoting PGC-1alpha-regulated mitochondrial energy homeostasis","volume":"177","author":"Qin","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059794","article-title":"Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NF\u03baB signaling pathway in rats","volume":"8","author":"Wan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b1125","first-page":"816","article-title":"Effect of matrine on regulating renal tubulointerstitial expression of MMP-3, TIMP-1 and FN","volume":"36","author":"Fu","year":"2005","journal-title":"J Sichuan Univ Med Sci"},{"key":"10.1016\/j.addr.2021.113911_b1130","first-page":"140","article-title":"Experimental study on effect of matrine in alleviating renal tubulointerstitial fibrosis in unilateral ureteral obstruction model","volume":"26","author":"Fu","year":"2006","journal-title":"Chin. J. Integr. Tradit. West Med."},{"key":"10.1016\/j.addr.2021.113911_b1135","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/0886022X.2016.1164185","article-title":"Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-\u03b21-Smad3 pathway","volume":"38","author":"Wang","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b1140","article-title":"Oxymatrine inhibits renal tubular EMT induced by high glucose via upregulation of SnoN and inhibition of TGF-\u03b21\/Smad signaling pathway","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113911_b1145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fphys.2020.00599","article-title":"Oxymatrine inhibits twist-mediated renal tubulointerstitial fibrosis by upregulating id2 expression","volume":"11","author":"Xiao","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b1150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ptr.3630","article-title":"Effects of ligustrazine on ureteral obstruction-induced renal tubulointerstitial fibrosis","volume":"26","author":"Yuan","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2021.113911_b1155","first-page":"7508","article-title":"Effects of tetramethylpyrazine in rats with unilateral ureteral obstruction renal fibrosis","volume":"16","author":"Li","year":"2012","journal-title":"Chin J Tissue Engineer Res"},{"key":"10.1016\/j.addr.2021.113911_b1160","first-page":"249","article-title":"Effect of ligustrazine on expression of MMP-9 and TIMP-1 in rats with renal interstitial fibrosis","volume":"25","author":"Li","year":"2012","journal-title":"Med Theor Prac"},{"key":"10.1016\/j.addr.2021.113911_b1165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/19336918.2019.1638691","article-title":"Caffeine inhibits hypoxia-induced renal fibroblast activation by antioxidant mechanism","volume":"13","author":"Nilnumkhum","year":"2019","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.addr.2021.113911_b1170","unstructured":"X.G. Dong, Z.M. An, M. Lu, H.C. Yang, J.X. Gu, Effect of tetrandrine on nephron in glomerular sclerosis rats, Chin. J. Integr. Tradit. West Nephrol. (2001) 384\u2013385+392."},{"key":"10.1016\/j.addr.2021.113911_b1175","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3892\/mmr.2017.6539","article-title":"Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model","volume":"15","author":"Itano","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b1180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.05.009","article-title":"Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of oxidative stress and TGF\u03b2 signaling","volume":"304","author":"Qin","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118855","article-title":"Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2\/STAT3\/SOCS1 pathway in streptozotocin-induced diabetic rats","volume":"265","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b1190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/cbin.10270","article-title":"Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway","volume":"38","author":"Wei","year":"2014","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.addr.2021.113911_b1195","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/10717544.2019.1642417","article-title":"Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study","volume":"26","author":"Yang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2021.113911_b1200","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/619720","article-title":"Ferulic acid attenuates TGF-\u03b21-induced renal cellular fibrosis in NRK-52E cells by inhibiting Smad\/ILK\/Snail pathway","volume":"2015","author":"Wei","year":"2015","journal-title":"Evid.-Based Compl. Alt."},{"key":"10.1016\/j.addr.2021.113911_b1205","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1039\/C9FO02398D","article-title":"Protective effect of ferulic acid on STZ-induced diabetic nephropathy in rats","volume":"11","author":"Qi","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.addr.2021.113911_b1210","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1464-410X.2011.10848.x","article-title":"Recoverability of renal functions after relief of partial ureteric obstruction of solitary kidney: impact of ferulic acid","volume":"110","author":"Shokeir","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.addr.2021.113911_b1215","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.pharep.2017.06.014","article-title":"Attenuation of renal damage in type I diabetic rats by umbelliferone-a coumarin derivative","volume":"69","author":"Garud","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.addr.2021.113911_b1220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2012.05.017","article-title":"Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats","volume":"692","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1225","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3389\/fphys.2018.01650","article-title":"Osthole ameliorates renal fibrosis in mice by suppressing fibroblast activation and epithelial-mesenchymal transition","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.addr.2021.113911_b1230","doi-asserted-by":"crossref","first-page":"22473","DOI":"10.3390\/ijms160922473","article-title":"Protective effects of MDG-1, a polysaccharide from Ophiopogon japonicus on diabetic nephropathy in diabetic KKAy mice","volume":"16","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phymed.2017.03.003","article-title":"Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy","volume":"30","author":"Li","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b1240","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/10715762.2015.1038258","volume":"49","author":"Li","year":"2015","journal-title":"Free Radic Res"},{"key":"10.1016\/j.addr.2021.113911_b1245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/821936","article-title":"Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation","volume":"2012","author":"Cui","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.addr.2021.113911_b1250","unstructured":"Q. Hu, In vitro screening and mechanism of traditional Chinese medicine against renal interstitial fibrosis, Chinese Academy of Medical Sciences & Peking Union Medical College, 2009."},{"key":"10.1016\/j.addr.2021.113911_b1255","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfp245","article-title":"In vitro anti-fibrotic activities of herbal compounds and herbs","volume":"24","author":"Hu","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.addr.2021.113911_b1260","article-title":"Establishment of renal fibrosis model in vitro and screening of traditional Chinese medicine compounds based on high content technology","author":"Sun","year":"2017","journal-title":"Beijing Univ TCM"},{"key":"10.1016\/j.addr.2021.113911_b1265","doi-asserted-by":"crossref","first-page":"7942614","DOI":"10.1155\/2018\/7942614","article-title":"Establishing a Cell-Based High-Content Screening Assay for TCM Compounds with Anti-Renal Fibrosis Effects","volume":"2018","author":"Wang","year":"2018","journal-title":"Evid Based Complement Alternat. Med."},{"key":"10.1016\/j.addr.2021.113911_b1270","first-page":"666","article-title":"Effective components of traditional Chinese medicine for regulating TGF- Beta1\/ Smads signaling pathway in hepatic fibrosis","volume":"44","author":"Wang","year":"2019","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"10.1016\/j.addr.2021.113911_b1275","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1021\/ci700155t","article-title":"Phytochemical informatics of traditional Chinese medicine and therapeutic relevance","volume":"47","author":"Ehrman","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.addr.2021.113911_b1280","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1476-5381.2011.01206.x","article-title":"Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy","volume":"162","author":"Meng","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1285","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.2147\/DDDT.S171286","article-title":"Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-\u03b21\/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy","volume":"12","author":"Du","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b1290","first-page":"144","article-title":"Effects of astragaloside and salvianolateon A on TGF-\u03b21 mRNA and CTGF mRNA in renal tissue of chronic renal failure rats","volume":"55","author":"Tang","year":"2014","journal-title":"J. Tradit. Chin. Medi."},{"key":"10.1016\/j.addr.2021.113911_b1295","unstructured":"L. Fu, Y.J. Li, Y.Y. Lai, C.Y. E., S.Y. Li, J. Feng, D. Wu, C.L. Chu, Q. Wang, Effects of Huangqi injection combined with Gegensu injection on TGF-\u03b21\/Smads and BMP-7\/Smad 5 signaling pathway in HK-2 cells, Global Tradit. Chin. Med. 12 (2019) 343\u2013347."},{"key":"10.1016\/j.addr.2021.113911_b1300","first-page":"942","article-title":"Effect of Astragalus injection combined with Puerarin injection on epithelial-mesenchymal transition of renal tubular epithelial cells in KKAy mice","volume":"34","author":"Gao","year":"2014","journal-title":"Chin. J. Gerontol."},{"key":"10.1016\/j.addr.2021.113911_b1305","first-page":"1","article-title":"Protective effects of quercetin and crocin in the kidneys and liver of obese Sprague-Dawley rats with Type 2 diabetes effects of quercetin and crocin on T2DM rats","author":"Lai","year":"2020","journal-title":"Human Exp. Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b1310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3892\/etm.2014.1841","article-title":"Protective effects of quercetin and hyperoside on renal fibrosis in rats with unilateral ureteral obstruction","volume":"8","author":"Yan","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.113911_b1315","article-title":"Intervention effect of compatibility of salvianolic acid A, B on PDGF-C\/PDGFR-\u03b1 signaling pathway in renal fibrosis","author":"Zhao","year":"2014","journal-title":"Zunyi. Med. Coll."},{"key":"10.1016\/j.addr.2021.113911_b1320","first-page":"895","article-title":"Intervention effect of salvianolic acid A, B on CTGF and Par-3 expression in the process of renal fibrosis","volume":"10","author":"Zhao","year":"2015","journal-title":"World Chin. Med."},{"key":"10.1016\/j.addr.2021.113911_b1325","first-page":"69","article-title":"Renal protection and antioxidant effect of emodin and apigenin on spontaneously hypertensive rats","volume":"34","author":"Ma","year":"2018","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"key":"10.1016\/j.addr.2021.113911_b1330","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.573118","article-title":"Pharmacokinetics and pharmacodynamics of the combination of rhein and curcumin in the treatment of chronic kidney disease in rats","volume":"11","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1335","doi-asserted-by":"crossref","first-page":"36984","DOI":"10.18632\/oncotarget.6100","article-title":"Treatment of renal fibrosis by rebalancing TGF-\u03b2\/Smad signaling with the combination of asiatic acid and naringenin","volume":"6","author":"Meng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2021.113911_b1340","doi-asserted-by":"crossref","unstructured":"D. Ganesan, A. Holkar, A. Albert, E. Paul, J. Mariakuttikan, G. Sadasivam Selvam, Combination of ramipril and rutin alleviate alloxan induced diabetic nephropathy targeting multiple stress pathways in vivo, Biomed. Pharmacother. 108 (2018) 1338\u20131346.","DOI":"10.1016\/j.biopha.2018.09.142"},{"key":"10.1016\/j.addr.2021.113911_b1345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.regpep.2013.03.005","article-title":"Effects of felodipine combined with puerarin on ACE2-Ang (1\u20137)-Mas axis in renovascular hypertensive rat","volume":"184","author":"Bai","year":"2013","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2021.113911_b1350","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s13577-019-00314-9","article-title":"Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-\u03b2 signaling pathway","volume":"33","author":"Ma","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.addr.2021.113911_b1355","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/DDDT.S224308","article-title":"Silibinin augments the antifibrotic effect of valsartan through inactivation of TGF-\u03b21 signaling in kidney","volume":"14","author":"Liu","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b1360","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2147\/DDDT.S245847","article-title":"Emodin retarded renal fibrosis through regulating HGF and TGF\u03b2-Smad signaling pathway","volume":"14","author":"Yang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113911_b1365","first-page":"826","article-title":"Effect of Tanshinone IIA combined with DAPT on Notch\/Jagged pathway proteins in renal tissue of UUO rat models","volume":"39","author":"Feng","year":"2019","journal-title":"Chin. J. Integr. Tradit. West Med."},{"key":"10.1016\/j.addr.2021.113911_b1370","article-title":"Effect of tanshinone IIA combined with DAPT on the expression of NICD and Rbp-Jk proteins in renal tissue of UUO model rats","author":"Feng","year":"2018","journal-title":"Zunyi. Med. Univ."},{"key":"10.1016\/j.addr.2021.113911_b1375","article-title":"Intervention effect of compatibility of tanshinone IIA and DAPT on Notch1\/Jagged1 signaling pathway in renal fibrosis","author":"Xu","year":"2019","journal-title":"J. Zunyi. Med. Univ."},{"key":"10.1016\/j.addr.2021.113911_b1380","first-page":"562","article-title":"Experimental study of tanshinone IIA combined with DAPT treatment on renal interstitial fibrosis in UUO rats","volume":"41","author":"Xu","year":"2018","journal-title":"J. Zunyi. Med. Univ."},{"key":"10.1016\/j.addr.2021.113911_b1385","first-page":"2403","article-title":"Clinical observation of tanshinone IIA sulfonate injection combined with insulin aspart 30 injection in treatment of diabetic nephropathy","volume":"33","author":"Qiao","year":"2018","journal-title":"Drugs Clinic"},{"key":"10.1016\/j.addr.2021.113911_b1390","first-page":"1966","article-title":"Ameliorative effect and mechanism of tanshinone IIA sodium sulfonate combined with dapagliflozin on diabetic rats with kidney injury","volume":"18","author":"Yue","year":"2020","journal-title":"Central South Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1395","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.34534","article-title":"Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis","volume":"64","author":"Kavian","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2021.113911_b1400","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-019-01734-y","article-title":"Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling","volume":"393","author":"Maghmomeh","year":"2020","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1405","first-page":"41","article-title":"The role of resveratrol in combination with irbesartan on anti-fibrosis in renal interstitial fibrosis rat models","volume":"17","author":"Li","year":"2017","journal-title":"China Trop. Med."},{"key":"10.1016\/j.addr.2021.113911_b1410","first-page":"1845","article-title":"The protective effect and mechanism of tetrandrine combined with prednisone for renal fibrosis rats caused by adriamycin","volume":"37","author":"Bai","year":"2016","journal-title":"Jilin. Med. J."},{"key":"10.1016\/j.addr.2021.113911_b1415","first-page":"30","article-title":"Effect and the mechanism of sodium tanshinone IIA sulfonate on renal interstitial fibrosis in rats","volume":"54","author":"Lv","year":"2014","journal-title":"Shandong Med. J."},{"key":"10.1016\/j.addr.2021.113911_b1420","article-title":"Inhibitory effect of sodium tanshinone II-A sulfonate on renal tubulointerstitial fibrosis in rats and investigate the mechanism of renal interstitial fibrosis","author":"Lv","year":"2014","journal-title":"Qingdao Univ."},{"key":"10.1016\/j.addr.2021.113911_b1425","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.toxlet.2017.07.212","article-title":"Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice","volume":"278","author":"Chen","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.addr.2021.113911_b1430","unstructured":"C.C. Zeng, X. Liu, W.W. Liu, L. Wang, J.G. Cheng, S.M. Chen, G.R. Chen, Protective effect of curcumin derivative B06 on kidney of type 2 diabetic rats, Chin. J. Appl. Physiol. 31 (2015) 38\u201342+100."},{"key":"10.1016\/j.addr.2021.113911_b1435","doi-asserted-by":"crossref","first-page":"6878795","DOI":"10.1155\/2017\/6878795","article-title":"Sinomenine hydrochloride attenuates renal fibrosis by inhibiting excessive autophagy induced by adriamycin: an experimental study","volume":"2017","author":"Zhao","year":"2017","journal-title":"Evid.-Based Compl. Alt."},{"key":"10.1016\/j.addr.2021.113911_b1440","doi-asserted-by":"crossref","unstructured":"Y. Zhang, M.M. Zhao, B. Yang, J.N. Zhao, Sinomenine hydrochloride alleviates renal fibrosis by inhibiting excessive autophagy, in: The 7th annual meeting of the professional committee of geriatrics of the World Federation of Chinese Medicine SocietiesZhengzhou, Henan, China, 2018, pp. 1.","DOI":"10.1155\/2017\/6878795"},{"key":"10.1016\/j.addr.2021.113911_b1445","first-page":"69","article-title":"Experimental study of sinomenine hydrochloride on renal interstitial fibrosis","author":"Song","year":"2006","journal-title":"Guid. J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1450","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2013.04.045","article-title":"Pentamethylquercetin ameliorates fibrosis in diabetic Goto-Kakizaki rat kidneys and mesangial cells with suppression of TGF-\u03b2\/Smads signaling","volume":"713","author":"Xin","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1455","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2019.03.020","article-title":"Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation","volume":"223","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2021.113911_b1460","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11255-016-1232-0","article-title":"Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats","volume":"48","author":"Cao","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1465","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.3892\/mmr.2017.7728","article-title":"Role of artesunate in TGF-\u03b21-induced renal tubular epithelial-mesenchymal transdifferentiation in NRK-52E cells","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.113911_b1470","doi-asserted-by":"crossref","unstructured":"G. Yan, Y. Wang, X. Han, Q. Zhang, H. Xie, J. Chen, Ji, C. Mao, T. Lu, A Modern technology applied in traditional Chinese medicine: progress and future of the nanotechnology in TCM, Dose Response 17 (2019) 1559325819872854.","DOI":"10.1177\/1559325819872854"},{"key":"10.1016\/j.addr.2021.113911_b1475","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3389\/fphar.2017.01002","article-title":"PhytoNanotechnology: enhancing delivery of plant based anti-cancer drugs","volume":"8","author":"Khan","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1480","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/IJN.S176013","article-title":"Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-\u03baB and Nrf2 signaling system","volume":"14","author":"Manna","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.113911_b1485","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.2147\/IJN.S146978","article-title":"Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium","volume":"12","author":"Tong","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.113911_b1490","first-page":"1156","article-title":"Research progress on targeted preparations of traditional Chinese medicine","volume":"52","author":"Jiang","year":"2021","journal-title":"Chin. Tradit. Herb Drugs"},{"key":"10.1016\/j.addr.2021.113911_b1495","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.05.006","article-title":"Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment","volume":"154\u2013155","author":"Zhang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113911_b1500","first-page":"13","article-title":"Recent advances in herbal nanomedicines for cancer treatment, Curr","author":"Pradhan","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1505","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/antiox8100466","article-title":"Nanoparticulated honokiol mitigates cisplatin-induced chronic kidney injury by maintaining mitochondria antioxidant capacity and reducing Caspase 3-associated cellular apoptosis","volume":"8","author":"Liu","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.addr.2021.113911_b1510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v33.i1.20","article-title":"Current trends in self-emulsifying drug delivery systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs","volume":"33","author":"Karwal","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2021.113911_b1515","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejps.2016.12.012","article-title":"Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-\u03b21 in AGEs-induced glomerular mesangial cells by promoting absorption","volume":"99","author":"Huang","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1520","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/mp800078a","article-title":"Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan","volume":"6","author":"Yuan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2021.113911_b1530","unstructured":"P. Xia, The mechanism and kidney-targeted delivery of tanshinone protect against cadmium-induced renal injury, Nanjing Univ TCM, 2020."},{"key":"10.1016\/j.addr.2021.113911_b1535","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1681\/ASN.2017010013","article-title":"Targeting anti-TGF-\u03b2 therapy to fibrotic kidneys with a dual specificity antibody approach","volume":"28","author":"McGaraughty","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1540","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.113911_b1545","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1159\/000488160","article-title":"Expression of the alpha8 integrin chain facilitates phagocytosis by renal mesangial cells","volume":"45","author":"Marek","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b1550","first-page":"1","article-title":"Codelivery of emodin and diammonium glycyrrhizinate by anti-alpha8 integrin-conjugated immunoliposomes for the treatment of renal fibrosis","volume":"2020","author":"Sun","year":"2020","journal-title":"J. Nanomater."},{"key":"10.1016\/j.addr.2021.113911_b1555","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.apsb.2020.10.016","article-title":"An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis","volume":"11","author":"Qin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2021.113911_b1560","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2013.10.041","article-title":"Peptide fragments of human serum albumin as novel renal targeting carriers","volume":"460","author":"Yuan","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1565","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2015.06.012","article-title":"Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin","volume":"94","author":"Yuan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2021.113911_b1570","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1039\/C9BM01290G","article-title":"Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury","volume":"7","author":"Deng","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1575","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1515\/chem-2020-0163","article-title":"Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models","volume":"18","author":"Tan","year":"2020","journal-title":"Open Chem."},{"key":"10.1016\/j.addr.2021.113911_b1580","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.ccr.2013.04.022","article-title":"Coordination polymer nanoparticles in medicine","volume":"257","author":"Novio","year":"2013","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.addr.2021.113911_b1585","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/ar200094a","article-title":"Supramolecular nanodevices: from design validation to theranostic nanomedicine","volume":"44","author":"Cabral","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2021.113911_b1590","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1016\/j.biomaterials.2014.04.106","article-title":"Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan","volume":"35","author":"Qiao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113911_b1595","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1039\/C7BM00811B","article-title":"Coordination-driven assembly of catechol-modified chitosan for the kidney-specific delivery of salvianolic acid B to treat renal fibrosis","volume":"6","author":"Li","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1600","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.113911_b1605","first-page":"452","article-title":"Synthesis of kidney-targeted prodrug triptolide-glucosamine conjugate","volume":"32","author":"Liu","year":"2017","journal-title":"West China J. Pharm. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1610","first-page":"1787","article-title":"Synthesis and in vitro evaluation of kidney-targeted prodrug triptolide-glucosamine conjugate","volume":"27","author":"Liu","year":"2018","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.addr.2021.113911_b1615","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/1061186X.2013.856011","article-title":"Conjugating glucosamine to triptolide to enhance its protective effect against renal ischemia-reperfusion injury and reduce its toxicity","volume":"22","author":"Zhou","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2021.113911_b1620","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/aps.2016.44","article-title":"Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia\/reperfusion renal injury in rats","volume":"37","author":"Fu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.addr.2021.113911_b1625","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.biomaterials.2008.11.035","article-title":"The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113911_b1630","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-020-01833-6","article-title":"Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin","volume":"21","author":"Zheng","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2021.113911_b1640","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/bc5005476","article-title":"Biodegradable tetra-PEG hydrogels as carriers for a releasable drug delivery system","volume":"26","author":"Henise","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2021.113911_b1645","doi-asserted-by":"crossref","unstructured":"A.A. D'Souza, R. Shegokar, Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications, Expert Opin. Drug Deliv. 13 (2016) 1257\u20131275.","DOI":"10.1080\/17425247.2016.1182485"},{"key":"10.1016\/j.addr.2021.113911_b1650","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2019.12.044","article-title":"Fundamental insights in PLGA degradation from thin film studies","volume":"319","author":"Machatschek","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.113911_b1655","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2018.08.002","article-title":"Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA\/nanoparticle delivery","volume":"287","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.113911_b1660","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","article-title":"Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics","volume":"92","author":"Ding","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.addr.2021.113911_b1665","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.113911_b1670","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acs.molpharmaceut.9b00770","article-title":"Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1675","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1016\/j.biomaterials.2012.03.020","article-title":"In vivo renal clearance, biodistribution, toxicity of gold nanoclusters","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113911_b1680","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1743-8977-8-16","article-title":"Subchronic inhalation toxicity of gold nanoparticles","volume":"8","author":"Sung","year":"2011","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b1685","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1177\/0748233714562623","article-title":"Oxidative stress following exposure to silver and gold nanoparticles in mice","volume":"32","author":"Shrivastava","year":"2016","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.addr.2021.113911_b1690","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8977-8-10","article-title":"Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells","volume":"8","author":"Pujalte","year":"2011","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b1695","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2369-14-96","article-title":"An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity","volume":"14","author":"Kermanizadeh","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1700","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/10408444.2016.1181047","article-title":"The effects of nanoparticles on the renal system","volume":"46","author":"Iavicoli","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.addr.2021.113911_b1705","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/17425241003777010","article-title":"Gold nanoparticles: opportunities and challenges in nanomedicine","volume":"7","author":"Arvizo","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2021.113911_b1710","first-page":"969","article-title":"Recent advancement on animal models of renal tubulointerstitial fibrosis","volume":"21","author":"Zhang","year":"2010","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"10.1016\/j.addr.2021.113911_b1715","first-page":"398","article-title":"Research progress of animal models of renal fibrosis and their characteristics","volume":"26","author":"Ma","year":"2018","journal-title":"Acta Lab Animal Sci. Sin."},{"key":"10.1016\/j.addr.2021.113911_b1720","first-page":"13","article-title":"Screening the experimental animal model of renal interstitial fibrosis from multi angle","volume":"38","author":"Zhang","year":"2016","journal-title":"J. Guiyang Coll. TCM"},{"key":"10.1016\/j.addr.2021.113911_b1725","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000445450","article-title":"Aging and the Kidneys: Anatomy, Physiology and Consequences for Defining Chronic Kidney Disease","volume":"134","author":"Glassock","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.addr.2021.113911_b1730","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.pmbts.2016.12.018","article-title":"The Kidney in Aging: Physiological Changes and Pathological Implications","volume":"146","author":"Sobamowo","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/invivo.11019","article-title":"Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies","volume":"31","author":"Nogueira","year":"2017","journal-title":"Vivo"},{"key":"10.1016\/j.addr.2021.113911_b1740","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/08860220701569846","article-title":"Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats","volume":"29","author":"Tofovic","year":"2007","journal-title":"Ren. Fail."},{"key":"10.1016\/j.addr.2021.113911_b1745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.08.003","article-title":"High doses of baicalin induces kidney injury and fibrosis through regulating TGF-\u03b2\/Smad signaling pathway","volume":"333","author":"Cai","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1750","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.33594\/000000072","article-title":"Caffeine accelerates cystic kidney disease in a Pkd1-deficient mouse model","volume":"52","author":"Meca","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.addr.2021.113911_b1755","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clnu.2011.11.003","article-title":"Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease","volume":"31","author":"Peng","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.addr.2021.113911_b1760","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.phymed.2018.12.024","article-title":"Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function","volume":"57","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2021.113911_b1765","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2008.183","article-title":"The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease","volume":"74","author":"Eardley","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.addr.2021.113911_b1770","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","article-title":"The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"Lancet Diabetes Endo"},{"key":"10.1016\/j.addr.2021.113911_b1775","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1780","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1681\/ASN.2016060640","article-title":"A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction","volume":"28","author":"Lafayette","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1785","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2021.113911_b1790","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.2008050482","article-title":"Avosentan reduces albumin excretion in diabetics with macroalbuminuria","volume":"20","author":"Wenzel","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1795","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.113911_b1800","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.2010101049","article-title":"Pirfenidone for diabetic nephropathy","volume":"22","author":"Sharma","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1805","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","author":"Adler","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1810","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-8587(15)00469-6","article-title":"Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial","volume":"4","author":"Heerspink","year":"2016","journal-title":"Lancet Diabetes Endo"},{"key":"10.1016\/j.addr.2021.113911_b1815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0390-4","article-title":"Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update","volume":"24","author":"Chen","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.addr.2021.113911_b1820","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.2014010012","article-title":"Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial","volume":"26","author":"Navarro-Gonz\u00e1lez","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2021.113911_b1825","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"A phase 2, double-blind, placebo-controlled, randomized study of fresolimumab in patients with steroid-resistant primary focal segmental glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.addr.2021.113911_b1830","first-page":"18","article-title":"Clinical study of 80 cases type 2 diabetic nephropathy treated by puerarin","volume":"19","author":"Wang","year":"2011","journal-title":"Chin. J. Trauma Disabil. Med."},{"key":"10.1016\/j.addr.2021.113911_b1835","unstructured":"D. Yan, Puerarin treatment of diabetic nephropathy, Chin. Med. Pharm. 3 (2013) 86\u201387+150."},{"key":"10.1016\/j.addr.2021.113911_b1840","doi-asserted-by":"crossref","unstructured":"M.A. Weir, M. Walsh, M.S. Cuerden, J.M. Sontrop, L.C. Chambers, A.X. Garg, Micro-particle curcumin for the treatment of chronic kidney disease-1: study protocol for a multicenter clinical trial, Can. J. Kidney Health Dis. 5 (2018) 2054358118813088.","DOI":"10.1177\/2054358118813088"},{"key":"10.1016\/j.addr.2021.113911_b1845","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.jrn.2016.01.013","article-title":"The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study","volume":"26","author":"Jimenez-Osorio","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.addr.2021.113911_b1850","first-page":"833","article-title":"Efficacy and safety of Breviscapine Injection in treatment of diabetic nephropathy: systematic review and Meta-analysis of randomized controlled trials","volume":"44","author":"Zhao","year":"2019","journal-title":"Chin. J. Clin. Mater. Med."},{"key":"10.1016\/j.addr.2021.113911_b1855","first-page":"218","article-title":"Progress in prevention and treatment of diabetic complications with breviscapine","volume":"26","author":"Xu","year":"2020","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.addr.2021.113911_b1860","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3892\/etm.2016.3483","article-title":"Effect of breviscapine injection on clinical parameters in diabetic nephropathy: A meta-analysis of randomized controlled trials","volume":"12","author":"Liu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.113911_b1865","first-page":"87","article-title":"Clinical effect of Sodium Tanshinone IIA Sulfonate Injection in the treatment of diabetic nephropathy","volume":"16","author":"Liang","year":"2020","journal-title":"J. Pract. Diabetol."},{"key":"10.1016\/j.addr.2021.113911_b1870","first-page":"2371","article-title":"Meta analysis of therapeutic efficacy of Sodium Tanshinone IIA Sulfonate Injection in treatment of diabetic kidney disease","volume":"37","author":"Xie","year":"2020","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1875","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1142\/S0192415X12500036","article-title":"Meta-analysis of the clinical effect of ligustrazine on diabetic nephropathy","volume":"40","author":"Wang","year":"2012","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.addr.2021.113911_b1880","first-page":"92","article-title":"To explore the curative effect of tripterygium glycosides in the treatment of diabetic nephropathy stageIV patients","volume":"27","author":"Yang","year":"2021","journal-title":"Contemp. Med."},{"key":"10.1016\/j.addr.2021.113911_b1885","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/j.jrn.2016.06.005","article-title":"Effects of Resveratrol Supplementation in Nrf2 and NF-kappaB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial","volume":"26","author":"Saldanha","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.addr.2021.113911_b1890","first-page":"341","article-title":"Clinical efficacy of gliquidone and puerarin injection in the treatment of type 2 diabetes mellitus and its influence on blood sugar and blood lipid","volume":"15","author":"Liu","year":"2018","journal-title":"Anti. Infect. Pharm."},{"key":"10.1016\/j.addr.2021.113911_b1895","first-page":"294","article-title":"Clinical efficacy and safety of piperazine ferulate combined with irbesartan in the treatment of diabetic nephropathy","volume":"32","author":"Wei","year":"2016","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2021.113911_b1900","first-page":"58","article-title":"Effect of Tripterygium Glycosides and Ramipril on Renal Functions and Serum Immunoglobulin Level in Elderly Patients with Primary Nephrotic Syndromes","volume":"16","author":"Zhang","year":"2019","journal-title":"Chin. J. Ration Drug Use"},{"key":"10.1016\/j.addr.2021.113911_b1905","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41565-020-00836-6","article-title":"Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis","volume":"16","author":"Hu","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2021.113911_b1910","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsnano.7b01522","article-title":"Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.113911_b1915","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113911_b1920","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151580","article-title":"Renal expression of sigma 1 receptors in diabetic rats","volume":"122","author":"Milardovic","year":"2020","journal-title":"Acta Histochem."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:01:56Z","timestamp":1759208516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21003045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":384,"alternative-id":["S0169409X21003045"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.113911","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic and delivery strategies of phytoconstituents for renal fibrosis","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.113911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113911"}}